- Home
- ANIP vs IAS Comparison
ANIP vs IAS Comparison
Compare ANIP & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- IAS
- Stock Information
- Founded
- ANIP 2001
- IAS 2009
- Country
- ANIP United States
- IAS United States
- Employees
- ANIP 897
- IAS N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- IAS Computer Software: Programming Data Processing
- Sector
- ANIP Health Care
- IAS Technology
- Exchange
- ANIP Nasdaq
- IAS Nasdaq
- Market Cap
- ANIP 2.0B
- IAS 1.7B
- IPO Year
- ANIP N/A
- IAS 2021
- Fundamental
- Price
- ANIP $90.60
- IAS $10.21
- Analyst Decision
- ANIP Strong Buy
- IAS Buy
- Analyst Count
- ANIP 7
- IAS 11
- Target Price
- ANIP $99.14
- IAS $13.57
- AVG Volume (30 Days)
- ANIP 326.9K
- IAS 2.5M
- Earning Date
- ANIP 11-07-2025
- IAS 11-10-2025
- Dividend Yield
- ANIP N/A
- IAS N/A
- EPS Growth
- ANIP N/A
- IAS 3014.55
- EPS
- ANIP N/A
- IAS 0.34
- Revenue
- ANIP $747,399,000.00
- IAS $569,836,000.00
- Revenue This Year
- ANIP $39.99
- IAS $14.72
- Revenue Next Year
- ANIP $9.57
- IAS $11.34
- P/E Ratio
- ANIP N/A
- IAS $30.14
- Revenue Growth
- ANIP 38.68
- IAS 14.39
- 52 Week Low
- ANIP $52.50
- IAS $6.26
- 52 Week High
- ANIP $99.50
- IAS $13.62
- Technical
- Relative Strength Index (RSI)
- ANIP 43.34
- IAS 68.23
- Support Level
- ANIP $90.06
- IAS $10.21
- Resistance Level
- ANIP $93.80
- IAS $10.23
- Average True Range (ATR)
- ANIP 2.85
- IAS 0.02
- MACD
- ANIP -0.23
- IAS -0.05
- Stochastic Oscillator
- ANIP 31.95
- IAS 60.00
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.